Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline add-on in schizophrenia
NCT05073640Phase 2Unknown
- Sponsor
- Mazra Mental Health Center
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in schizophrenia, sponsored by Mazra Mental Health Center. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05073640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073640.